My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Johnson & Johnson (NY:JNJ)

201.93 -0.55 (-0.27%)

Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

99 100 Next >

Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years? ↗

September 21, 2025

The trillion-dollar club will probably need to make room for at least one Dividend King in the coming years.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits ↗

September 20, 2025

Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.

Via Benzinga

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill ↗

September 20, 2025

A high yield is only one part of the story when it comes to picking dividend stocks.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson Confronts the End of its Talc Legacy with Multi-Billion Dollar Settlements

September 19, 2025

Johnson & Johnson (NYSE: JNJ) is navigating a critical juncture in its protracted legal battle over talc-based baby powder. The healthcare behemoth has announced a tentative $700 million settlement...

Via MarketMinute

Topics Bankruptcy Death Lawsuit

J&J’s Investigational Plaque Psoriasis Drug Outperforms Bristol Myers’ Sotyktu In Study ↗

September 17, 2025

Via Stocktwits

P&G's Q3 2025: Sales Miss Overshadows Earnings Beat Amidst Global Headwinds

September 19, 2025

Procter & Gamble (NYSE: PG) recently disclosed its fiscal third-quarter 2025 results, presenting a nuanced financial picture that has stirred investor sentiment. While the consumer goods titan managed...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Johnson & Johnson Unleashes Triple Threat: Bladder Cancer Breakthrough, Psoriasis Game-Changer, and Myasthenia Gravis Milestone Signal New Pharma Era

September 19, 2025

Johnson & Johnson (NYSE: JNJ) is making significant waves in the pharmaceutical landscape, announcing a trio of pivotal developments that underscore its robust pipeline and strategic focus on unmet...

Via MarketMinute

Big Pharma Eyes China: J&J And Roche Reportedly In Talks For Henlius’ Experimental Cancer Drug ↗

September 15, 2025

Via Stocktwits

Lilly's $5 Billion Virginia Investment: A Game Changer for GLP-1 and Oncology Drug Production

September 19, 2025

Eli Lilly and Company (NYSE: LLY) has announced a colossal $5 billion investment to establish a new, state-of-the-art manufacturing facility in Goochland County, Virginia. This significant expansion, a...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes

September 19, 2025

Eli Lilly and Company (NYSE: LLY) is making significant waves in the oncology landscape with a series of major announcements concerning two of its innovative cancer therapies: Olomorasib and Jaypirca...

Via MarketMinute

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients ↗

September 19, 2025

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

Via Benzinga

Can Regeneron Change The Paradigm In Multiple Myeloma — And Undercut J&J? ↗

September 19, 2025

The company is looking to take on Johnson & Johnson in treating patients with a precursor to multiple myeloma.

Via Investor's Business Daily

Recent Report Shows That Rep. Thomas Kean Bought Up to $45K Worth of Amcor Stock ↗

September 19, 2025

Via Benzinga

8 Dividend Growth Stocks Every Investor Should Consider ↗

September 19, 2025

These dividend powerhouses compound wealth through decades of consecutive increases and sustainable payout ratios.

Via The Motley Fool

Topics Artificial Intelligence Economy

Melanoma Data Study Boosts J&J Partner Nanobiotix Stock On Thursday ↗

September 18, 2025

Nanobiotix reported melanoma study data showing JNJ-1900 delivered 47.4% response rate, 78.9% disease control, and 14.6 months survival.

Via Benzinga

Intuitive Surgical: A Steady Hand in a Storm of AI Hype?

September 18, 2025

In a financial landscape increasingly dominated by the exhilarating, often volatile, narrative of artificial intelligence, Intuitive Surgical (NASDAQ: ISRG) stands as a testament to steady, fundamental...

Via MarketMinute

Topics Artificial Intelligence Supply Chain

Federal Reserve Navigates Stagflationary Headwinds with Dovish Pivot

September 18, 2025

Washington D.C. - The U.S. Federal Reserve finds itself at a critical juncture, facing an economic environment that is increasingly raising the specter of "stagflation" – a challenging combination of...

Via MarketMinute

Topics Economy Supply Chain World Trade

What the Options Market Tells Us About Johnson & Johnson ↗

September 18, 2025

Via Benzinga

The Specter of Stagflation: Is the Economy Headed for Stagnant Growth and High Inflation?

September 17, 2025

The U.S. Federal Reserve’s recent decision to cut interest rates has sent a tremor of concern through financial markets, sparking fears of a potential return to stagflation—an economic phenomenon...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trials ↗

September 17, 2025

Johnson & Johnson and Protagonist Therapeutics announced new data from their Phase 3 studies to treat severe plaque psoriasis.

Via Benzinga

Intuitive Surgical's Stellar Q2 2025 Performance Propels Robotic Surgery Market Forward

September 17, 2025

Sunnyvale, CA – September 17, 2025 – Intuitive Surgical (NASDAQ: ISRG), the pioneer and global leader in robotic-assisted surgery, has once again demonstrated its formidable market position with a...

Via MarketMinute

Topics Artificial Intelligence Supply Chain

A Precarious Ascent: Stock Market Bulls Grapple with Stubborn Inflation and a Cooling Job Market

September 17, 2025

The financial markets find themselves in a fascinating, if precarious, dance. Despite a recent surge in stock market performance, with the S&P 500 ([SPX]) registering robust gains in recent years,...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Johnson & Johnson (NYSE:JNJ): A Dividend Stock with Lasting Financial Strength ↗

September 17, 2025

Johnson & Johnson (JNJ) is a top dividend stock with a 2.91% yield, over 10 years of growth, and strong financials for reliable income.

Via Chartmill

GSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In America ↗

September 16, 2025

The plan includes $1.2 billion for a new biologics factory in Upper Merion, Pennsylvania, along with AI upgrades and expanded drug production across existing U.S. sites.

Via Stocktwits

Topics Artificial Intelligence Government World Trade

Navigating the Storm: Investment Strategies for an Unpredictable 2025

September 16, 2025

The financial landscape is bracing for a turbulent 2025, as expert consensus points towards a significant uptick in market volatility. This anticipated shift, driven by a complex interplay of global...

Via MarketMinute

Topics Artificial Intelligence Bonds Climate Change

3 Dividend Stocks to Hold Through Market Volatility This Fall ↗

September 16, 2025

Interest rate cuts may not decrease market volatility; discover three dividend stocks that can deliver stability, income, and growth during this fall

Via MarketBeat

Topics Economy

Monetary Easing on the Horizon: Investors Brace for 2025 Rate Cuts, Fueling a Shift to Risk Assets

September 16, 2025

Central banks worldwide, spearheaded by the U.S. Federal Reserve, are signaling a significant pivot towards monetary easing in 2025. This anticipated shift, driven by a weakening labor market and...

Via MarketMinute

Topics Bonds Economy Supply Chain

Market Mania Meets Economic Malaise: Record Highs Clash with Persistent Headwinds in Q3 2025

September 16, 2025

The third quarter of 2025 has been a period of stark contrasts for the global financial markets. While major U.S. stock indices like the S&P 500 and the Dow Jones Industrial Average (DJIA) have soared...

Via MarketMinute

Topics Economy Intellectual Property Stocks

3 Dividend-Paying ETFs to Buy in September Even If the S&P 500 Sells Off ↗

September 16, 2025

Dividend-paying growth stocks and covered call ETFs provide opportunities to generate income even in a declining stock market.

Via The Motley Fool

Topics ETFs Stocks

3 Dividend Growers That Fly Under the Radar ↗

September 15, 2025

These three companies may have what it takes to continue to build on their strong history of dividend payments even if the economy continues to sour.

Via MarketBeat

Topics Earnings Economy

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.